Published: 31 Jul 2022 | Report Code: 10248649 | Pages: 173
Global pharmacovigilance and drug safety software market will reach $432.3 million by 2031, growing by 7.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 82 tables and 92 figures, this 173-page report “Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global pharmacovigilance and drug safety software market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Region. Based on Functionality, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Adverse Event Reporting Software • Drug Safety Audits Software • Issue Tracking Software • Fully Integrated Software Based on Clinical Phase, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pre-clinical • Phase I • Phase II • Phase III • Phase IV By Method, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Spontaneous Reporting • Intensified ADR Reporting • Targeted Spontaneous Reporting • Cohort Event Monitoring • EHR Mining By Delivery Mode, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • On-premise Delivery • On-demand Delivery By Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Respiratory Disorders • Cardiology • Neurology • Immunology • Pain Management • Other Indications By End Users, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical and Biotechnology Companies • Contract Research Organizations (CROs) • Business Process Outsourcing Firms (BPOs) • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE?Saudi Arabia? South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Functionality, Delivery Mode and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Ab Cube Accenture PLC ArisGlobal LLC Cognizant Technology Solutions Corporation Ennov Solutions Inc. Extedo GmbH Honeywell International Inc. (Sparta Systems Inc.) IQVIA Inc. Max Application Oracle Corporation Sarjen Systems Pvt. Ltd. United BioSource LLC Veeva Systems Inc. Wipro Limited (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents:
1 Introduction 10 1.1 Industry Definition and Research Scope 10 1.1.1 Industry Definition 10 1.1.2 Research Scope 11 1.2 Research Methodology 14 1.2.1 Overview of Market Research Methodology 14 1.2.2 Market Assumption 15 1.2.3 Secondary Data 15 1.2.4 Primary Data 15 1.2.5 Data Filtration and Model Design 16 1.2.6 Market Size/Share Estimation 17 1.2.7 Research Limitations 18 1.3 Executive Summary 19 2 Market Overview and Dynamics 22 2.1 Market Size and Forecast 22 2.1.1 Impact of COVID-19 on World Economy 23 2.1.2 Impact of COVID-19 on the Market 27 2.2 Major Growth Drivers 29 2.3 Market Restraints and Challenges 34 2.4 Emerging Opportunities and Market Trends 37 2.5 Porter’s Fiver Forces Analysis 41 3 Segmentation of Global Market by Functionality 45 3.1 Market Overview by Functionality 45 3.2 Adverse Event Reporting Software 47 3.3 Drug Safety Audits Software 48 3.4 Issue Tracking Software 49 3.5 Fully Integrated Software 50 4 Segmentation of Global Market by Clinical Phase 51 4.1 Market Overview by Clinical Phase 51 4.2 Pre-clinical 53 4.3 Phase I 54 4.4 Phase II 55 4.5 Phase III 56 4.6 Phase IV 57 5 Segmentation of Global Market by Method 58 5.1 Market Overview by Method 58 5.2 Spontaneous Reporting 60 5.3 Intensified ADR Reporting 61 5.4 Targeted Spontaneous Reporting 62 5.5 Cohort Event Monitoring 63 5.6 EHR Mining 64 6 Segmentation of Global Market by Delivery Mode 65 6.1 Market Overview by Delivery Mode 65 6.2 On-premise Delivery 67 6.3 On-demand Delivery 68 7 Segmentation of Global Market by Indication 69 7.1 Market Overview by Indication 69 7.2 Oncology 71 7.3 Respiratory Disorders 72 7.4 Cardiology 73 7.5 Neurology 74 7.6 Immunology 75 7.7 Pain Management 76 7.8 Other Indications 77 8 Segmentation of Global Market by End User 78 8.1 Market Overview by End User 78 8.2 Pharmaceutical and Biotechnology Companies 80 8.3 Contract Research Organizations (CROs) 81 8.4 Business Process Outsourcing Firms (BPOs) 82 8.5 Other End Users 83 9 Segmentation of Global Market by Region 84 9.1 Geographic Market Overview 2021-2031 84 9.2 North America Market 2021-2031 by Country 88 9.2.1 Overview of North America Market 88 9.2.2 U.S. 92 9.2.3 Canada 95 9.2.4 Mexico 97 9.3 European Market 2021-2031 by Country 99 9.3.1 Overview of European Market 99 9.3.2 Germany 103 9.3.3 U.K. 105 9.3.4 France 107 9.3.5 Spain 109 9.3.6 Italy 111 9.3.7 Netherlands 113 9.3.8 Rest of European Market 115 9.4 Asia-Pacific Market 2021-2031 by Country 117 9.4.1 Overview of Asia-Pacific Market 117 9.4.2 Japan 121 9.4.3 China 124 9.4.4 Australia 126 9.4.5 India 128 9.4.6 South Korea 130 9.4.7 Rest of APAC Region 132 9.5 South America Market 2021-2031 by Country 134 9.5.1 Argentina 137 9.5.2 Brazil 139 9.5.3 Chile 141 9.5.4 Rest of South America Market 143 9.6 MEA Market 2021-2031 by Country 144 9.6.1 UAE 147 9.6.2 Saudi Arabia 149 9.6.3 South Africa 151 9.6.4 Other National Markets 153 10 Competitive Landscape 154 10.1 Overview of Key Vendors 154 10.2 New Product Launch, Partnership, Investment, and M&A 157 10.3 Company Profiles 158 Ab Cube 158 Accenture PLC 160 ArisGlobal LLC 161 Cognizant Technology Solutions Corporation 162 Ennov Solutions Inc. 163 Extedo GmbH 164 Honeywell International Inc. (Sparta Systems Inc.) 165 IQVIA Inc. 166 Max Application 167 Oracle Corporation 168 Sarjen Systems Pvt. Ltd. 169 United BioSource LLC 170 Veeva Systems Inc. 171 Wipro Limited 172 RELATED REPORTS 173
List of Tables: Table 1. Snapshot of Global Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 20 Table 2. World Economic Outlook, 2021-2031 24 Table 3. World Economic Outlook, 2021-2023 25 Table 4. Main Product Trends and Market Opportunities in Global Pharmacovigilance and Drug Safety Software Market 37 Table 5. Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 45 Table 6. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 51 Table 7. Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 58 Table 8. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 65 Table 9. Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 69 Table 10. Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 78 Table 11. Global Pharmacovigilance and Drug Safety Software Market by Region, 2021-2031, $ mn 85 Table 12. Leading National Pharmacovigilance and Drug Safety Software Market, 2021 and 2031, $ mn 87 Table 13. North America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 90 Table 14. U.S. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 94 Table 15. U.S. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 94 Table 16. U.S. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 94 Table 17. Canada Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 96 Table 18. Canada Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 96 Table 19. Canada Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 96 Table 20. Mexico Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 98 Table 21. Mexico Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 98 Table 22. Mexico Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 98 Table 23. Europe Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 102 Table 24. Germany Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 104 Table 25. Germany Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 104 Table 26. Germany Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 104 Table 27. U.K. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 106 Table 28. U.K. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 106 Table 29. U.K. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 106 Table 30. France Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 108 Table 31. France Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 108 Table 32. France Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 108 Table 33. Spain Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 110 Table 34. Spain Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 110 Table 35. Spain Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 110 Table 36. Italy Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 112 Table 37. Italy Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 112 Table 38. Italy Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 112 Table 39. Netherlands Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 114 Table 40. Netherlands Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 114 Table 41. Netherlands Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 114 Table 42. Pharmacovigilance and Drug Safety Software Market in Rest of Europe by Country, 2021-2031, $ mn 116 Table 43. APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 119 Table 44. Japan Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 123 Table 45. Japan Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 123 Table 46. Japan Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 123 Table 47. China Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 125 Table 48. China Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 125 Table 49. China Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 125 Table 50. Australia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 127 Table 51. Australia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 127 Table 52. Australia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 127 Table 53. India Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 129 Table 54. India Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 129 Table 55. India Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 129 Table 56. South Korea Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 131 Table 57. South Korea Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 131 Table 58. South Korea Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 131 Table 59. Pharmacovigilance and Drug Safety Software Market in Rest of APAC by Country/Region, 2021-2031, $ mn 133 Table 60. South America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 136 Table 61. Argentina Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 138 Table 62. Argentina Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 138 Table 63. Argentina Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 138 Table 64. Brazil Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 140 Table 65. Brazil Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 140 Table 66. Brazil Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 140 Table 67. Chile Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 142 Table 68. Chile Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 142 Table 69. Chile Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 142 Table 70. MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 146 Table 71. UAE Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 148 Table 72. UAE Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 148 Table 73. UAE Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 148 Table 74. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 150 Table 75. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 150 Table 76. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 150 Table 77. South Africa Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 152 Table 78. South Africa Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 152 Table 79. South Africa Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 152 Table 80. Ab Cube: Company Snapshot 158 Table 81. Ab Cube: Business Segmentation 159 Table 82. Ab Cube: Product Portfolio 159
List of Figures: Figure 1. Research Method Flow Chart 14 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17 Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19 Figure 4. Global Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 22 Figure 5. Impact of COVID-19 on Business 27 Figure 6. Primary Drivers and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market 29 Figure 7. Percentage of Trial Participants by Country, 2015-2019 32 Figure 8. World Drug Discovery Market, 2019-2030, $ mn 33 Figure 9. Primary Restraints and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market 34 Figure 10. Investment Opportunity Analysis 38 Figure 11. Porter’s Fiver Forces Analysis of Global Pharmacovigilance and Drug Safety Software Market 41 Figure 12. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, % of Revenue 46 Figure 13. Global Addressable Market Cap in 2022-2031 by Functionality, Value ($ mn) and Share (%) 46 Figure 14. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Adverse Event Reporting Software, 2021-2031, $ mn 47 Figure 15. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Drug Safety Audits Software, 2021-2031, $ mn 48 Figure 16. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Issue Tracking Software, 2021-2031, $ mn 49 Figure 17. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Fully Integrated Software, 2021-2031, $ mn 50 Figure 18. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, % of Sales Revenue 52 Figure 19. Global Addressable Market Cap in 2022-2031 by Clinical Phase, Value ($ mn) and Share (%) 52 Figure 20. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Pre-clinical, 2021-2031, $ mn 53 Figure 21. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase I, 2021-2031, $ mn 54 Figure 22. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase II, 2021-2031, $ mn 55 Figure 23. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase III, 2021-2031, $ mn 56 Figure 24. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase IV, 2021-2031, $ mn 57 Figure 25. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, % of Sales Revenue 59 Figure 26. Global Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%) 59 Figure 27. Global Pharmacovigilance and Drug Safety Software Market by Method: Spontaneous Reporting, 2021-2031, $ mn 60 Figure 28. Global Pharmacovigilance and Drug Safety Software Market by Method: Intensified ADR Reporting, 2021-2031, $ mn 61 Figure 29. Global Pharmacovigilance and Drug Safety Software Market by Method: Targeted Spontaneous Reporting, 2021-2031, $ mn 62 Figure 30. Global Pharmacovigilance and Drug Safety Software Market by Method: Cohort Event Monitoring, 2021-2031, $ mn 63 Figure 31. Global Pharmacovigilance and Drug Safety Software Market by Method: EHR Mining, 2021-2031, $ mn 64 Figure 32. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, % of Revenue 66 Figure 33. Global Addressable Market Cap in 2022-2031 by Delivery Mode, Value ($ mn) and Share (%) 66 Figure 34. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-premise Delivery, 2021-2031, $ mn 67 Figure 35. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-demand Delivery, 2021-2031, $ mn 68 Figure 36. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, % of Revenue 70 Figure 37. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 70 Figure 38. Global Pharmacovigilance and Drug Safety Software Market by Indication: Oncology, 2021-2031, $ mn 71 Figure 39. Global Pharmacovigilance and Drug Safety Software Market by Indication: Respiratory Disorders, 2021-2031, $ mn 72 Figure 40. Global Pharmacovigilance and Drug Safety Software Market by Indication: Cardiology, 2021-2031, $ mn 73 Figure 41. Global Pharmacovigilance and Drug Safety Software Market by Indication: Neurology, 2021-2031, $ mn 74 Figure 42. Global Pharmacovigilance and Drug Safety Software Market by Indication: Immunology, 2021-2031, $ mn 75 Figure 43. Global Pharmacovigilance and Drug Safety Software Market by Indication: Pain Management, 2021-2031, $ mn 76 Figure 44. Global Pharmacovigilance and Drug Safety Software Market by Indication: Other Indications, 2021-2031, $ mn 77 Figure 45. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, % of Revenue 78 Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 79 Figure 47. Global Pharmacovigilance and Drug Safety Software Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn 80 Figure 48. Global Pharmacovigilance and Drug Safety Software Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 81 Figure 49. Global Pharmacovigilance and Drug Safety Software Market by End User: Business Process Outsourcing Firms (BPOs), 2021-2031, $ mn 82 Figure 50. Global Pharmacovigilance and Drug Safety Software Market by End User: Other End Users, 2021-2031, $ mn 83 Figure 51. Global Market Snapshot by Region 84 Figure 52. Geographic Spread of Worldwide Pharmacovigilance and Drug Safety Software Market, 2021-2031, % of Sales Revenue 85 Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 86 Figure 54. North American Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 89 Figure 55. Breakdown of North America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 90 Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 91 Figure 57. U.S. Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 93 Figure 58. Canada Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 95 Figure 59. Pharmacovigilance and Drug Safety Software Market in Mexico, 2021-2031, $ mn 97 Figure 60. European Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 100 Figure 61. Breakdown of European Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 101 Figure 62. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 102 Figure 63. Pharmacovigilance and Drug Safety Software Market in Germany, 2021-2031, $ mn 103 Figure 64. Pharmacovigilance and Drug Safety Software Market in U.K., 2021-2031, $ mn 105 Figure 65. Pharmacovigilance and Drug Safety Software Market in France, 2021-2031, $ mn 107 Figure 66. Pharmacovigilance and Drug Safety Software Market in Spain, 2021-2031, $ mn 109 Figure 67. Pharmacovigilance and Drug Safety Software Market in Italy, 2021-2031, $ mn 111 Figure 68. Pharmacovigilance and Drug Safety Software Market in Netherlands, 2021-2031, $ mn 113 Figure 69. Pharmacovigilance and Drug Safety Software Market in Rest of Europe, 2021-2031, $ mn 115 Figure 70. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 118 Figure 71. Breakdown of APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 118 Figure 72. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 120 Figure 73. Pharmacovigilance and Drug Safety Software Market in Japan, 2021-2031, $ mn 122 Figure 74. Pharmacovigilance and Drug Safety Software Market in China, 2021-2031, $ mn 124 Figure 75. Pharmacovigilance and Drug Safety Software Market in Australia, 2021-2031, $ mn 126 Figure 76. Pharmacovigilance and Drug Safety Software Market in India, 2021-2031, $ mn 128 Figure 77. Pharmacovigilance and Drug Safety Software Market in South Korea, 2021-2031, $ mn 130 Figure 78. Pharmacovigilance and Drug Safety Software Market in Rest of APAC, 2021-2031, $ mn 132 Figure 79. South America Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 135 Figure 80. Breakdown of South America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 135 Figure 81. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 136 Figure 82. Pharmacovigilance and Drug Safety Software Market in Argentina, 2021-2031, $ mn 137 Figure 83. Pharmacovigilance and Drug Safety Software Market in Brazil, 2021-2031, $ mn 139 Figure 84. Pharmacovigilance and Drug Safety Software Market in Chile, 2021-2031, $ mn 141 Figure 85. Pharmacovigilance and Drug Safety Software Market in Rest of South America, 2021-2031, $ mn 143 Figure 86. Pharmacovigilance and Drug Safety Software Market in Middle East and Africa (MEA), 2021-2031, $ mn 145 Figure 87. Breakdown of MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 145 Figure 88. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 146 Figure 89. Pharmacovigilance and Drug Safety Software Market in UAE, 2021-2031, $ mn 147 Figure 90. Pharmacovigilance and Drug Safety Software Market in Saudi Arabia, 2021-2031, $ mn 149 Figure 91. Pharmacovigilance and Drug Safety Software Market in South Africa, 2021-2031, $ mn 151 Figure 92. Growth Stage of Global Pharmacovigilance and Drug Safety Software Industry over the Forecast Period 154
Selected Key Players: Ab Cube Accenture PLC ArisGlobal LLC Cognizant Technology Solutions Corporation Ennov Solutions Inc. Extedo GmbH Honeywell International Inc. (Sparta Systems Inc.) IQVIA Inc. Max Application Oracle Corporation Sarjen Systems Pvt. Ltd. United BioSource LLC Veeva Systems Inc. Wipro Limited (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)